Jaguar Health shares surge 10.41% intraday as CEO presents at Life Sciences investor forum, highlighting near-term catalysts.

Jaguar Health surged 10.41% intraday after announcing that CEO Lisa Conte would present at the Life Sciences Virtual Investor Forum on March 12, 2026. The presentation, scheduled for 2:00 PM Eastern, aims to update investors on near-term catalysts and strategic initiatives, including advancements in its plant-derived gastrointestinal therapies. The event follows recent restructuring efforts to strengthen the company’s balance sheet by reducing royalty and debt obligations, though specifics on these measures were not detailed in the provided content. The market’s positive reaction likely reflects optimism about the company’s pipeline updates and improved financial positioning, as such forums typically heighten investor interest in a firm’s growth prospects.